ClinVar Miner

Submissions for variant NM_014363.6(SACS):c.2182C>T (p.Arg728Ter) (rs752059006)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000393719 SCV000329912 pathogenic not provided 2016-05-31 criteria provided, single submitter clinical testing The R728X variant in the SACS gene has been reported previously in the homozygous and compound heterozygous states in association with cerebellar ataxia (Vermeer et al., 2008; Synofzik et al., 2013; Karaca et al., 2015). This variant is predicted to cause loss of normal protein function through protein truncation. The R728X variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R728X as a pathogenic variant.
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine RCV000454220 SCV000537976 likely pathogenic Abnormality of brain morphology criteria provided, single submitter research
CMT Laboratory,Bogazici University RCV000984212 SCV001548315 pathogenic Charlevoix-Saguenay spastic ataxia 2020-12-01 criteria provided, single submitter clinical testing
Counsyl RCV000984212 SCV001132279 likely pathogenic Charlevoix-Saguenay spastic ataxia 2014-01-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.